SCHEMBL17786283

SCHEMBL17786283

CC(C)CCn1c(C=O)nc2c1c(=O)n(C)c(=O)n2C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MAPK1 P28482 1/20 0.58
ALDH1A1 P00352 13/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
MAPT P10636 4/20 0.53
NPSR1 Q6W5P4 4/20 0.53
GAA P10253 2/20 0.53
HPGD P15428 1/20 0.53
MAOA P21397 3/20 0.51
MAOB P27338 3/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 1/20 0.51
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13652736 0.84 USP2 (0.58) TSHRSMN1; SMN2MAPK1MEN1KMT2A
SCHEMBL17786274 0.80 CYP1A2 (0.68) TSHRSMN1; SMN2MAPK1ALDH1A1MEN1
SCHEMBL13659056 0.79 ALDH1A1 (0.53) TSHRMAPK1ALDH1A1GAACYP1A2
SCHEMBL17786276 0.78 ALDH1A1 (0.63) TSHRSMN1; SMN2MAPK1ALDH1A1MEN1
SCHEMBL27474615 0.77 ADORA2A (0.56) ALDH1A1KMT2AHPGDMAOBCYP1A2
SCHEMBL17207521 0.73 ALDH1A1 (1.00) TSHRMAPK1ALDH1A1MEN1KMT2A
SCHEMBL13652737 0.72 TSHR (0.44) TSHRMAPK1ALDH1A1KMT2AGAA
SCHEMBL4379838 0.71 TSHR (0.57) TSHRSMN1; SMN2MAPK1ALDH1A1MEN1
SCHEMBL17786270 0.70 LMNA (0.64) TSHRSMN1; SMN2MAPK1ALDH1A1MEN1
SCHEMBL17207523 0.70 ALDH1A1 (1.00) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016086008-A1 SMALL MOLECULE ALDEHYDE DEHYDROGENASE INHIBITORS AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-06-02 WO disclosed